Sort
326,823 grants matching “clinical trial”
Costimulatory Mechanisms of Autoimmunity (Composite)
$2,183,882David A. Hafler · Yale University · P01 · FY2011 · AI
Alliance for Clinical Trials in Oncology Operations Center - BIQSFP Supplements
$2,183,801Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2021 · CA
Administrative Core
$2,183,801Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2021 · CA
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
$2,183,683Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2015 · CA
Androgen Receptor Action in Castration Resistant Prostate Cancer
$2,183,516Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2013 · CA
Development of Next-generation Pharmacotherapy for Opioid Use Disorders
$2,183,507Nurulain T Zaveri · Astraea Therapeutics, Llc · UH3 · FY2023 · DA
Genome Wide Association Coordinating Center
$2,183,494Bruce S. Weir · University Of Washington · U01 · FY2008 · HG
Recombinant Adeno Associated Virus Vectors for Gene Transfer
$2,183,420Robert Kotin · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
The Center for Enhancing Triage and Utilization for Depression and Emergent Suicidality (ETUDES) in Pediatric Primary Care
$2,183,419David A. Brent · University Of Pittsburgh At Pittsburgh · P50 · FY2018 · MH
Neurologic Emergencies Treatment Trials Network: Clinical Coordinating Center
$2,183,322William G Barsan · University Of Michigan At Ann Arbor · U01 · FY2015 · NS
Specialized Program of Research Excellence (SPORE) in Leukemia
$2,183,320Daniel C Link · Washington University · P50 · FY2025 · CA
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
$2,183,234Peter G Stock · University Of California, San Francisco · U01 · FY2017 · AI
SPORE in Breast Cancer
$2,182,992Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2006 · CA
MICHIGAN CANCER RESEARCH CONSORTIUM
$2,182,501Philip J Stella · Saint Joseph Mercy Health System · UG1 · FY2014 · CA
Molecular and Clinical Approaches to Colon Cancer Precursors
$2,182,390Randall Walter Burt · University Of Utah · P01 · FY2012 · CA
Mirtazapine for methamphetamine use disorder: drug-drug interaction study
$2,182,386Phillip O Coffin · Public Health Foundation Enterprises · U01 · FY2021 · DA
Multimodal MRI in Multiple Sclerosis
$2,182,260Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Preclinical and clinical evaluation of the NMDA modulator NYX-783 for OUD
$2,182,107Ralph J Dileone · Yale University · UG3 · FY2019 · DA
Costimulatory Mechanisms of Autoimmunity (Composite)
$2,181,894David A. Hafler · Yale University · P01 · FY2012 · AI
Boosting mind-body mechanisms and outcomes for chronic pain
$2,181,778Vitaly Napadow · Massachusetts General Hospital · P01 · FY2021 · AT
Boosting mind-body mechanisms and outcomes for chronic pain
$2,181,778Vitaly Napadow · Massachusetts General Hospital · P01 · FY2023 · AT
Boosting mind-body mechanisms and outcomes for chronic pain
$2,181,778Vitaly Napadow · Massachusetts General Hospital · P01 · FY2022 · AT
AZITHROMYCIN AND CORONARY ARTERY DISEASE
$2,181,731University Of Washington · U10 · FY2000 · HL
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,181,629Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences · UM1 · FY2021 · AI
Rush Center for Urban Health Equity
$2,181,604Lynda H Powell · Rush University Medical Center · P50 · FY2011 · HL